

|
 |

 |
 |
New Milford Hospital is a regional healthcare provider that is a member of the world-renowned NewYork-Presbyterian Healthcare System. New Milford has an extraordinary tradition of warm and caring personal attention backed by top-notch physicians, world-class technology and the newest, most advanced diagnostic and treatment options available. Your healthcare team of highly trained physicians, nurses, technicians and administrators is determined and committed to improving the health and quality of life of those we serve.
We are also affiliated with the New Milford Visiting Nurse Association, which is a subsidiary of the New Milford Hospital Holding Corporation and helps ensure that our patients have the option of professional care before their admission, if needed, as well as help after discharge from the hospital, if medically necessary.
Executive Team
Meet the President and Chief Executive Officer: Joseph P. Frolkis, MD, PhD
Joseph P. Frolkis, MD, PhD, was appointed as President and CEO of New Milford Hospital on February 1, 2007. Dr. Frolkis was previously the Hospital’s Vice President for Medical Affairs and Director of the Cardiovascular Disease Prevention Program since 2005.
Prior to his arrival in Connecticut, Dr. Frolkis served at the University Hospitals of Cleveland and was Director of Clinical Operations in the Preventive Cardiology Program at The Cleveland Clinic. At University Hospitals, he directed the center for cardiovascular disease reduction and was chief of the division of general internal medicine, geriatrics and health care research. He was also an associate professor of medicine, epidemiology and biostatistics at the Case Western Reserve University School of Medicine.
After his undergraduate studies at the University of Rochester, New York, Dr. Frolkis earned a medical degree from Case Western Reserve University, Ohio, completed post-graduate training at Mt. Sinai Medical Center, Ohio, and a master’s degree and PhD in clinical psychology from Boston University, Massachusetts.
Dr. Frolkis is the author of numerous articles in the medical literature, including published studies in the New England Journal of Medicine, the American Journal of Medicine, and the American Journal of Cardiology. His clinical trials in cardiovascular treatment have been supported by the National Heart, Lung and Blood Institute, Merck & Co., Parke-Davis, Novartis and Pfizer, among others.
Executive Management:
Susan Iovino, Executive Vice President, Chief Operating Officer and Chief Nursing Officer
Dennis Primavera, Vice President, Finance and Facilities
Sally Herlihy, Vice President, Regulatory Compliance
Robert Sommer, Vice President, Human Resources
Marydale DeBor, Vice President, External Affairs
Joan Puglia, MD, Medical Staff President
Board of Directors:
Henry Allen, MD
Charles Barlow
Martin Begun
Roberta Buddle
Pamela Cantor, MD
William Chappell
Lynette Cornell
Carl D'Andrea, MD
Anthea Disney
Kevin Dumas
Patricia Dyer
Barry Ginsburg
Lawrence Greenhaus
Evan Hack, MD
Kenneth Hecken
Theodore Hollander
Spencer Houldin
Harold Kamm, MD
|
Robert Lenz
Adriana Mnuchin
Peter P. Mullen
Thomas Mulvihill, Secretary
Carol Nelson
Stella G. Newman
John Novogrod
Terry Pellegrini
James Preston, Chairman
Jacqueline Markham Priaulx
Ellen Rittman
Walter "Trip" Rothschild
C. Carter Walker
Arthur Weinshank, Esq.
Edward Zane, MD
Andrea Wilson, Ex Officio
Joseph Frolkis, MD, PhD, President & CEO
Susan Iovino, Executive Vice President, COO & CNO |
|
 |